Fulbreca 250mg Injection
Marketer
RPG Life Sciences Ltd
Salt Composition
Fulvestrant (250mg)
Overview Fulbreca 250mg Injection
Faslodex 250mg Injection, an estrogen receptor antagonist, treats postmenopausal breast cancer. It functions by modulating estrogen levels, thereby inhibiting cancer cell proliferation. Administered intramuscularly under medical supervision, dosage and frequency are determined by individual needs and prescribed treatment plan. Treatment duration adheres to the physician's prescription. Common adverse effects encompass injection site reactions, headache, nausea, vomiting, and allergic responses. Report any concerning or severe side effects immediately to your physician; management strategies may be available. Prior to initiating treatment, disclose any history of renal or hepatic impairment, bleeding disorders, anticoagulant use, or concurrent medications to your doctor. Furthermore, inform your physician of any pregnancy, pregnancy plans, or breastfeeding.
Uses of Fulbreca 250mg Injection
Malignant mammary tumor
Major Benefits of Fulbreca 250mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Fulbreca 250mg Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Fulbreca 250mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
How Fulbreca 250mg Injection works:
Fulbreca 250mg Injection inhibits estrogen's activity within breast cancer cells, potentially suppressing or halting the proliferation of estrogen-dependent tumors.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while using Fulbreca 250mg Injection. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Administering Fulbreca 250mg Injection during pregnancy is contraindicated due to confirmed harm to the fetus. Exceptions may exist in critical circumstances where a physician deems the potential advantages outweigh the risks. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Fulbreca 250mg Injection is contraindicated during lactation. Evidence indicates potential infant toxicity.
DrivingSAFE
Driving ability is typically unaffected by a 250mg Fulbreca injection.
KidneyCAUTION
For patients with severe kidney impairment, administering Fulbreca 250mg Injection requires careful consideration and potential dosage modification. Data regarding Fulbreca 250mg Injection use in such patients is limited. A physician's consultation is recommended. Dosage alteration isn't suggested for individuals experiencing mild to moderate kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Fulbreca 250mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Fulbreca 250mg Injection :
Omit a Fulbreca 250mg Injection dose? Seek your physician's advice.
Facts to Know About Fulbreca 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Estrogen-Derived Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Behavior Class | Estrogen receptor blocker |
3,018 People bought this recently